Reckitt Benckiser Group Plc with ticker (LON:RKT) now has a potential upside of 5.4% according to Berenberg Bank.
RKT.L
Berenberg Bank set a target price of 5,177 GBX for the company, which when compared to the Reckitt Benckiser Group Plc share price of 4,912 GBX at opening today (04/11/2024) indicates a potential upside of 5.4%. Trading has ranged between 4,034 (52 week low) and 5,886 (52 week high) with an average of 1,613,065 shares exchanging hands daily. The market capitalisation at the time of writing is £44,460,850,000.
Reckitt Benckiser Group PLC (Reckitt) is a United Kingdom-based global consumer goods company. The Company’s operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.
Reckitt Benckiser Group Plc 5.4% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Latest Company News
Reckitt Benckiser delivered a 7% rise in like-for-like group revenue for Q3 2025, supported by 6.7% growth in Core Reckitt and strong momentum in Emerging Markets.
Reckitt Benckiser delivered a strong H1 2025, with Core Reckitt like‑for‑like net revenues up 4.2% and Emerging Markets growth of 12.8%. Adjusted operating profit margin improved by 110 bps to 24.6%, supporting a 5% rise in the interim dividend and an upgrade to full‑year LFL net revenue guidance above 4% for Core Reckitt.
Reckitt Benckiser Group plc has entered into an agreement to sell its Essential Home business to Advent International for an enterprise value of up to US$4.8 billion, while retaining a 30 percent equity stake.
Reckitt Benckiser appoints Mahesh Madhavan and Stefan Oschmann as Non-Executive Directors to strengthen its Board from January 2025.
Reckitt Benckiser Group PLC (LON:RKT) reports Q1 2024 results. Hygiene net revenue up 7.1%, Health up 1.0%, Nutrition down 9.9%. On track for full year delivery.
Reckitt Benckiser Group PLC (LON:RKT) has released its final results for 2023, showing positive growth in Hygiene and Health sectors. CEO Kris Licht looks ahead to continued progress in 2024.
